General - Vascular Intervention
Payments companies reported to CMS as associated with General - Vascular Intervention. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with General - Vascular Intervention, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with General - Vascular Intervention
These are the largest totals companies reported as associated with General - Vascular Intervention. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Nikhil Cordeiro | New York, NY | Interventional Cardiology | $12,500.00 |
| Anvar Babaev | New York, NY | Interventional Cardiology | $7,562.50 |
| Michael Attubato | New York, NY | Interventional Cardiology | $4,062.50 |
| Alexander Slotwiner | New York, NY | Interventional Cardiology | $4,062.50 |
| Nicholas Petruzzi | Galloway, NJ | Vascular & Interventional Radiology | $3,332.33 |
| John Park | Omaha, NE | Vascular Surgery | $3,274.82 |
| Pratik Dalal | Chandler, AZ | Interventional Cardiology | $3,031.02 |
| Elizabeth Genovese | Philadelphia, PA | Vascular Surgery | $2,918.87 |
| William Gray | Wynnewood, PA | Interventional Cardiology | $2,895.10 |
| Bradley Strnad | Fort Wayne, IN | Diagnostic Radiology | $2,792.68 |
Prescribed General - Vascular Intervention?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.